Literature DB >> 22304731

S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

Fei Zhao1, Bastian Hoechst, Austin Duffy, Jaba Gamrekelashvili, Suzanne Fioravanti, Michael P Manns, Tim F Greten, Firouzeh Korangy.   

Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that negatively regulate the immune response during tumour progression, inflammation and infection. Only limited data are available on human MDSC because of the lack of specific markers. We have identified members of the S100 protein family-S100A8, S100A9 and S100A12 - specifically expressed in CD14(+) HLA-DR(-/low) MDSC. S100A9 staining in combination with anti-CD14 could be used to identify MDSC in whole blood from patients with colon cancer. An increase in the population of CD14(+) S100A9(high) MDSC was observed in the peripheral blood from colon cancer patients in comparison with healthy controls. Finally, nitric oxide synthase expression, a hallmark of MDSC, was induced in CD14(+) S100A9(high) upon lipopolysaccharide/interferon-γ stimulation. We propose S100 proteins as useful markers for the analysis and further characterization of human MDSC. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22304731      PMCID: PMC3403264          DOI: 10.1111/j.1365-2567.2012.03566.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

Review 2.  S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.

Authors:  Dirk Foell; Helmut Wittkowski; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2006-08-30       Impact factor: 4.962

Review 3.  Proinflammatory S100 proteins in arthritis and autoimmune disease.

Authors:  Dirk Foell; Johannes Roth
Journal:  Arthritis Rheum       Date:  2004-12

4.  Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.

Authors:  Bastian Hoechst; Jaba Gamrekelashvili; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

5.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Authors:  Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

6.  Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.

Authors:  B Almand; J I Clark; E Nikitina; J van Beynen; N R English; S C Knight; D P Carbone; D I Gabrilovich
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14.

Authors:  T Vogl; C Pröpper; M Hartmann; A Strey; K Strupat; C van den Bos; C Sorg; J Roth
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

Review 8.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature).

Authors:  Ingo Marenholz; Claus W Heizmann; Günter Fritz
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

9.  Probing the S100 protein family through genomic and functional analysis.

Authors:  Timothy Ravasi; Kenneth Hsu; Jesse Goyette; Kate Schroder; Zheng Yang; Farid Rahimi; Les P Miranda; Paul F Alewood; David A Hume; Carolyn Geczy
Journal:  Genomics       Date:  2004-07       Impact factor: 5.736

10.  Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.

Authors:  Paolo Serafini; Kristen Meckel; Michael Kelso; Kimberly Noonan; Joseph Califano; Wayne Koch; Luigi Dolcetti; Vincenzo Bronte; Ivan Borrello
Journal:  J Exp Med       Date:  2006-11-13       Impact factor: 14.307

View more
  79 in total

1.  Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab.

Authors:  Jeffrey Weber; Geoffrey Gibney; Ragini Kudchadkar; Bin Yu; Pingyan Cheng; Alberto J Martinez; Jodie Kroeger; Allison Richards; Lori McCormick; Valerie Moberg; Heather Cronin; Xiuhua Zhao; Michael Schell; Yian Ann Chen
Journal:  Cancer Immunol Res       Date:  2016-02-12       Impact factor: 11.151

2.  Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow.

Authors:  Mikael Roussel; P Brent Ferrell; Allison R Greenplate; Faustine Lhomme; Simon Le Gallou; Kirsten E Diggins; Douglas B Johnson; Jonathan M Irish
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

Review 3.  Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation.

Authors:  Joseph R Scalea; Young Suk Lee; Eduardo Davila; Jonathan S Bromberg
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

4.  CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer.

Authors:  Sherven Sharma; Steven Dubinett; Ravi Salgia
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

5.  MDSC: a new player in HIV immunopathogenesis.

Authors:  Bernard J C Macatangay; Alan L Landay; Charles R Rinaldo
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

Review 6.  Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors:  Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

7.  Role of myeloid-derived suppressor cells in autoimmune disease.

Authors:  Kristen R Crook; Peng Liu
Journal:  World J Immunol       Date:  2014-03-27

8.  Neutrophils and the S100A9 protein critically regulate granuloma formation.

Authors:  Yuya Yoshioka; Tatsuaki Mizutani; Satoshi Mizuta; Ayumi Miyamoto; Satoru Murata; Toshiaki Ano; Hiroshi Ichise; Daisuke Morita; Hiroyuki Yamada; Yoshihiko Hoshino; Tatsuaki Tsuruyama; Masahiko Sugita
Journal:  Blood Adv       Date:  2016-12-14

Review 9.  The immunobiology of myeloid-derived suppressor cells in cancer.

Authors:  Morteza Motallebnezhad; Farhad Jadidi-Niaragh; Elmira Safaie Qamsari; Salman Bagheri; Tohid Gharibi; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2015-11-26

Review 10.  The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.

Authors:  Dennis Lindau; Paul Gielen; Michiel Kroesen; Pieter Wesseling; Gosse J Adema
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.